Stock Earnings

Question 1

What are Syndax Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Syndax Pharmaceuticals Inc has a total asset of $724, Net loss of $-318

Question 2

What are the key financial ratios for SNDX?

Accepted Answer

Syndax Pharmaceuticals Inc's Current ratio is 1.66, has a Net margin is -1,382.6, sales per share of $0.26.

Question 3

How is Syndax Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Syndax Pharmaceuticals Inc largest revenue segment is Syndax Pharmaceuticals, at a revenue of 23,680,000 in the most earnings release.For geography, United States is the primary market for Syndax Pharmaceuticals Inc, at a revenue of 23,680,000.

Question 4

Is Syndax Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Syndax Pharmaceuticals Inc has a net loss of $-318

Question 5

Does Syndax Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Syndax Pharmaceuticals Inc has liability of 436

Question 6

How many outstanding shares for Syndax Pharmaceuticals Inc?

Accepted Answer

Syndax Pharmaceuticals Inc has a total outstanding shares of 85.69

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	111	23	0	0	139	1
Revenue Growth (YoY)	594%	--	--	-100%	13,800%	0%
Cost of Revenue	5	0	--	--	--	--
Gross Profit	106	22	--	--	--	--
Selling, General & Admin	167	120	66	33	25	22
Research & Development	245	241	163	118	88	50
Operating Expenses	413	362	229	151	113	72
Other Non Operating Income (Expenses)	-1	0	0	0	0	0
Pretax Income	-311	-318	-209	-149	24	-73
Income Tax Expense	--	--	--	--	--	--
Net Income	-311	-318	-209	-149	24	-77
Net Income Growth	5%	52%	40%	-721%	-131%	38%
Shares Outstanding (Diluted)	86.62	85.62	70.37	60.8	53.6	41.3
Shares Change (YoY)	2%	22%	16%	13%	30%	35%
EPS (Diluted)	-3.6	-3.72	-2.97	-2.46	0.46	-1.87
EPS Growth	3%	25%	21%	-635%	-125%	2%
Free Cash Flow	-310	-274	-160	-133	29	-71
Free Cash Flow Per Share	-3.57	-3.2	-2.27	-2.18	0.54	-1.71
Gross Margin	95.49%	95.65%	--	--	--	--
Operating Margin	-275.67%	-1,473.91%	0%	0%	18.7%	-7,100%
Profit Margin	-280.18%	-1,382.6%	0%	0%	17.26%	-7,700%
Free Cash Flow Margin	-279.27%	-1,191.3%	0%	0%	20.86%	-7,100%
EBITDA	-306	-339	-229	-151	26	-71
EBITDA Margin	-275.67%	-1,473.91%	0%	0%	18.7%	-7,100%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-306	-339	-229	-151	26	-71
EBIT Margin	-275.67%	-1,473.91%	0%	0%	18.7%	-7,100%
Effective Tax Rate	--	--	--	--	--	--

Syndax Pharmaceuticals Inc (SNDX) Price

SNDX Stock Price Chart

SNDX Income

Follow-Up Questions